Literature DB >> 11035054

Accumulation of RXR alpha during activation of cycling human T lymphocytes: modulation of RXRE transactivation function by mitogen-activated protein kinase pathways.

M Ishaq1, M Fan, V Natarajan.   

Abstract

We have previously reported that the activation of resting human immature peripheral blood T (PBT) lymphocytes is associated with the loss of retinoid X receptor alpha (RXRalpha) expression. In the present study, we have demonstrated that, unlike resting cells, activation of cycling human mature PBT lymphocytes, and T lymphocyte leukemia cell lines is accompanied by the accumulation of RXRalpha mRNA and protein. Interestingly, cyclosporin A further augmented RXRalpha expression, indicating the involvement of calcineurin pathways in the process. 9-cis retinoic acid inhibited the accumulation, suggesting that retinoids can regulate the synthesis of their own receptors during T cell activation. Transfection analysis in Jurkat cells, using RXRE-dependent reporter assays, showed that RXRalpha accumulated during T cell activation was transcriptionally inactive. To investigate the mechanism of such inhibition, the role of two mitogen-activated protein kinase pathways, c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK), in modulating RXRE-dependent transcription, was explored. The expression of constitutively active MAP/ERK kinase kinase 1 (MEKK1) inhibited RXRE-dependent transcription, whereas dominant negative MEKK1 increased the transcription, indicating the involvement of JNK signaling pathways in the process. In contrast, expression of constitutively active MEK1, which activates ERK pathway, enhanced RXRE-dependent activation. When both were activated simultaneously, JNK pathway was dominant over ERK pathway and resulted in inhibition of RXRE-mediated transcription. These data demonstrate a dual regulatory control of RXRalpha expression during the activation of resting and cycling T lymphocytes and indicate a dynamic balance between JNK and ERK pathways in modulating RXRE-mediated transactivation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035054     DOI: 10.4049/jimmunol.165.8.4217

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  RARgamma and TRbeta expressions are decreased in PBMC and SWAT of obese subjects in weight gain.

Authors:  C Bairras; A Redonnet; H Dabadie; H Gin; C Atgie; V Pallet; P Higueret; C Noël-Suberville
Journal:  J Physiol Biochem       Date:  2010-04-13       Impact factor: 4.158

2.  Induction of apoptosis in human prostate cancer cells by insulin-like growth factor binding protein-3 does not require binding to retinoid X receptor-alpha.

Authors:  Giovanna Zappala; Cem Elbi; Joanna Edwards; Julie Gorenstein; Matthew M Rechler; Nisan Bhattacharyya
Journal:  Endocrinology       Date:  2007-12-27       Impact factor: 4.736

3.  Mitogenic effect of orphan receptor TR3 and its regulation by MEKK1 in lung cancer cells.

Authors:  Siva Kumar Kolluri; Nathalie Bruey-Sedano; Xihua Cao; Bingzhen Lin; Feng Lin; Young-Hoon Han; Marcia I Dawson; Xiao-kun Zhang
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

4.  LIM kinase 1 - dependent cofilin 1 pathway and actin dynamics mediate nuclear retinoid receptor function in T lymphocytes.

Authors:  Mohammad Ishaq; Bor-Ruei Lin; Marjorie Bosche; Xin Zheng; Jun Yang; Dawei Huang; Richard A Lempicki; Angelica Aguilera-Gutierrez; Ven Natarajan
Journal:  BMC Mol Biol       Date:  2011-09-16       Impact factor: 2.946

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.